Matinas BioPharma Holdings (MTNB) Current Assets (2013 - 2026)
Matinas BioPharma Holdings (MTNB) recorded Current Assets of $1.14 million in Q2 2026, down 84.3% from $7.27 million a year earlier and down 59.4% from the prior quarter.
Matinas BioPharma Holdings (MTNB) Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Matinas BioPharma Holdings reported Current Assets of $4.08 million, down 49.2% from FY2024.
- Annual Current Assets has declined for five straight years, with a five-year compound annual growth rate of -41.9% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $8.03 million in FY2024 (-48.4%), $15.54 million in FY2023 (-55.0%), $34.53 million in FY2022 (-32.3%) and $50.99 million in FY2021 (-17.2%).
- The Q2 2026 figure is the lowest quarterly Current Assets since Q2 2016.
- On a year-over-year basis, Current Assets has declined for 22 consecutive quarters, with an average decline of 52.1% over the last eight quarters.
- The year-over-year decline in Current Assets has ranged between 13.4% (Q3 2021) and 84.3% (Q2 2026) over the last five years.
- Per Business Quant, the preceding three quarters came in at $2.82 million (Q1 2026), $4.08 million (Q4 2025) and $5.65 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Matinas BioPharma Holdings | 16.27 Mn | 3.68 Mn | - | 1.14 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Mar 31, 2026 | 2.82 Mn |
| Dec 31, 2025 | 4.08 Mn |
| Sep 30, 2025 | 5.65 Mn |
| Jun 30, 2025 | 7.27 Mn |
| Mar 31, 2025 | 7.55 Mn |
| Dec 31, 2024 | 8.03 Mn |
| Sep 30, 2024 | 11.74 Mn |
| Jun 30, 2024 | 15.29 Mn |
| Mar 31, 2024 | 10.29 Mn |
| Dec 31, 2023 | 15.54 Mn |
| Sep 30, 2023 | 19.99 Mn |
| Jun 30, 2023 | 24.00 Mn |
| Mar 31, 2023 | 28.21 Mn |
| Dec 31, 2022 | 34.53 Mn |
| Sep 30, 2022 | 37.10 Mn |
| Jun 30, 2022 | 41.92 Mn |
| Mar 31, 2022 | 45.12 Mn |
| Dec 31, 2021 | 50.99 Mn |
| Sep 30, 2021 | 56.48 Mn |
Matinas BioPharma Holdings Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=MTNB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();